๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study

โœ Scribed by M Sasaki; Y Nakanuma; YS Kim


Book ID
118686448
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
344 KB
Volume
24
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Characterization of apomucin expression
โœ M Sasaki; Y Nakanuma; Y S Kim ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 345 KB

of their genes suggest that they have unique roles and distri-To date, seven apomucins have been characterized bution. [9][10][11][12][13][14][15][16][17][18] Changes in apomucin expression in carcinoma tisand their expression in malignant and premalignant lesues and their precursor lesions, as well

Expression of glycoconjugates during int
โœ Takahiro Sanzen; Kazuharu Yoshida; Motoko Sasaki; Tadashi Terada; Yasuni Nakanum ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 982 KB

We investigated the expression of carbohydrate residues on the developing intrahepatic bile ducts of rats. At 17 days of gestation, immature biliary cells around the portal vein close to the hepatic hilum assumed one of the following forms: slitlike lumen, incomplete, or complete bile ductule-like s

Expression of e-cadherin, ฮฑ-catenin, ฮฒ-c
โœ Keigo Ashida; Tadashi Terada; Yukisato Kitamura; Nobuaki Kaibara ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB

Immunolocalization of E-cadherin (E-cad), โฃ-catenin, โค-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC). We, therefore, immunohistochemically examined the expression of E-cad, โฃ-catenin, โค-catenin, CD44 standard (CD44s), and CD44 variants (CD44v) including CD44v5, CD44

Frequent expression of MUC1 apomucin on
โœ M Sasaki; Y Nakanuma ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 323 KB ๐Ÿ‘ 1 views

restricted recognition process. (HEPATOLOGY 1996;23: MUC1 apomucin is a specific target tumor antigen rec-1313-1317.) ognized by cytotoxic T cells in a major histocompatibility complex (MHC) unrestricted fashion in patients with pancreatic and breast cancer. This T-cell-mediated im- Mucin is compos